Consensus conference on the management of heart failure;Perché una Consensus Conference sui percorsi assistenziali del paziente con scompenso cardiaco

Giornale Italiano di Cardiologia

Volumn 7, Issue 6, 2006, Pages 387-432

  Di Lenarda, Andrea ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Care pathways; Heart failure clinics; Heart failure management; Integrated network; Multidisciplinary Intervention

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DEFIBRILLATION; DISEASE REGISTRY; ELECTROCARDIOGRAPHY; ELECTRONIC MEDICAL RECORD; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITALIZATION; HUMAN; INCIDENCE; MEDICAL RECORD REVIEW; MEDICAL SOCIETY; MORTALITY; NATIONAL HEALTH SERVICE; OUTPATIENT CARE; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PROFESSIONAL PRACTICE; QUALITY OF LIFE; CLINICAL PATHWAY; CONGESTIVE HEART FAILURE;

CRITICAL PATHWAYS; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 33751286117     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (104)

1. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to update the 2001 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol 2005; 46: 1116-43.
2. Swedberg K, Cleland J, Dargie H, et al, for the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2005; 26: 1115-40.
3. McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J 1993:14: 1158-62.
4. Massie BM, Shah NB. The heart failure epidemic: magnitude of the problem and potential mitigating approaches. Curr Opin Cardiol 1996; 11: 221-6.
5. Clozel M. Heart failure - an epidemic of the 21st century? 25th Institut Pasteur Euroconference. 26-27 June 2000, Paris, France. Drugs 2000; 3: 1169-70.
6. Redfield MM. Heart failure - an epidemic of uncertain proportions. N Engl J Med 2002; 347: 1442-4.
7. Liao L, Jollis JG, Anstrom KJ, et al. Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med 2006; 166: 112-8.
8. Lee WC, Chavez YE, Baker T, Luce BR. Economic burden of heart failure: a summary of recent literature. Heart Lung 2004; 33: 362-71.
9. Politi C, Deales A, Cicchitelli F, et al. Analisi dei costi sanitari per lo scompenso cardiaco nella regione Marche. Pharmacoeconomics Italian Research Articles 2005; 7: 165-75.
10. Gwadry-Sridhar FH, Flintoft V, Lee DS, Lee H, Guyatt GH. A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Arch Intern Med 2004; 164: 2315-20.
11. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multi-disciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004; 44: 810-8.
12. Phillips C, Wright SM, Kern D, Singa RM, Shepperd S, Rubin HR. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure. A meta-analysis. JAMA 2004; 291: 1358-67.
13. Capomolla S, Alunni GF. La prevenzione delle recidive: i modelli di management. In: Tarantini L, ed. La prevenzione dello scompenso cardiaco. Roma: 11 Pensiero Scientifico Editore, 2005: 183-212.
14. Federazione Italiana di Cardiologia. Struttura e organizzazione funzionale della Cardiologia. Ital Heart J Suppl 2003; 4: 881-930.
15. http://www.ministerosalute.it/resources/static/psn/documenti/ psn-2003-2005.PDF
16. Accordo Collettivo Nazionale per la disciplina dei rapporti con i medici di medicina generale ai sensi dell'art. 8 Dlgs n. 502 1992. Reso esecutivo con intesa sancita in Conferenza Stato/Regioni Rep. 2272 del 23/03/2005.
17. Linee guida per le attività di riabilitazione, Ministero della Sanità, Gazzetta Ufficiale 30 maggio 1998, n. 124.
18. Linea Guida Cardiologia Riabilitativa e Prevenzione Secondaria. http://www.pnlg.it/LG/016/016.pdf
19. Lee DS, Tran C, Flintoft V, Grant FC, Liu PP, Tu JV, for the Canadian Cardiovascular Outcomes Research Team/Canadian Cardiovascular Society Heart Failure Quality Indicator Panel. CCORT/CCS quality indicators for congestive heart failure care. Can J Cardiol 2003; 19: 357-64.
20. Bonow RO, Bennett S, Casey DE Jr., et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol 2005; 46: 1144-78.
21. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003; 108: 977-82.
22. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000; 35: 1628-37.
23. Kannel WB, D'Agostino RB, Silbershatz H, Belanger AJ, Wilson PW, Levy D. Profile for estimating risk of heart failure. Arch Intern Med 1999; 159: 1197-204.
24. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557-62.
25. Verdecchia P, Angeli F, Gattobigio R, Sardone M, Porcellati C. Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value. Hypertension 2005; 45: 412-8.
26. Tarantini L, Di Lenarda A, Velussi M, et al. Diabete mellito, disfunzione ventricolare sinistra e scompenso cardiaco. Ital Heart J Suppl 2004; 5: 605-15.
27. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-41.
28. Vaur L, Gueret P, Lievre M, Chabaud S, Passa P. Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (Type 2 Diabetes, Hypertension, Cardiovascular Events and Ramipril) study. Diabetes Care 2003; 26: 855-60.
29. Carr AA, Kowey PR, Devereux RB, et al. Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies. Am J Cardiol 2005; 96: 1530-6.
30. Baker DW, Bahler RC, Finkelhor RS, Lauer MS. Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure. Am Heart J 2003; 146: 736-40.
31. Nielsen OW, McDonagh TA, Robb SD, Dargie HJ. Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population. J Am Coll Cardiol 2003; 41: 113-20.
32. Hedberg P, Loonberg I, Jonason T, Nilsson G, Pehrsson K, Ringqvist I. Electrocardiogram and B-type natriuretic peptide as screening tools for left ventricular systolic dysfunction in a population-based sample of 75-year-old men and women. Am Heart J 2004; 148: 524-9.
33. Hobbs FD, Davis RC, Roalfe AK, Hare R, Davies MK. Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations. Heart 2004; 90: 866-70.
34. Galasko GIW, Barnes SC, Collinson P, Lahiri A, Senior R. What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? Eur Heart J 2006; 27: 193-200.
35. Heidenreich PA, Gubens MA, Fonarow GC, Konstam MA, Stevenson LW, Shekelle PG. Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. J Am Coll Cardiol 2004; 43: 1019-26.
36. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-63.
37. Morrow DA, de Lemos JA, Blazing MA, et al, for the A to Z Investigators. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA 2005; 294: 2866-71.
38. Hellermann JP, Jacobsen SJ, Redfield MM, Reeder GS, Weston SA, Roger VL. Heart failure after myocardial infarction: clinical presentation and survival. Eur J Heart Fail 2005; 7: 119-25.
39. Lewis EF, Moye LA, Rouleau JL, et al. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol 2003; 42: 1446-53.
40. Gheorghiade M, Zannad F, Sopko G, et al. Acute heart failure syndromes: current state and framework for future research. Circulation 2005; 112: 3958-68.
41. Bellotti P, Badano LP, Acquarone N, et al. Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. The OSCUR study. Outcome dello Scompenso Cardiaco in Relazione all'Utilizzo delle Risorse. Eur Heart J 2001; 22: 596-604.
42. Di Lenarda A, Scherillo M, Maggioni AP, et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds - the TEMISTOCLE study. Am Heart J 2003; 146: E12.
43. Bellis P. Progetto MINERVA: origini, metodologia, obiettivi. Torino: Centro Scientifico Editore, 2004.
44. SEOSI Investigators. Survey on heart failure in Italian hospital cardiology units. Results of the SEOSI study. Eur Heart J 1997; 18: 1457-64.
45. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003; 290: 2581-7.
46. Fonarow G, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ, for the ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005; 293: 572-80.
47. Tavazzi L, Maggioni AP, Lucci D, et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 2006; 27: 1207-15.
48. Nieminen MS, Bohm M, Cowie MR, et al, ESC Committe, for Practice Guidelines. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416.
49. Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 2004; 44: 1328-33.
50. Bettencourt P, Ferreira S, Azevedo A, Ferreira A. Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcomes after hospital discharge in patients with heart failure. Am J Med 2002; 113: 215-9.
51. Nohria A, Tsang SW, Fang JC, et a]. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003; 41: 1797-804.
52. Butler J, Hanumanthu S, Chomsky D, Wilson JR. Frequency of low-risk hospital admissions for heart failure. Am J Cardiol 1998; 81: 41-4.
53. Smith WR, Poses RM, McClish DK, et al. Prognostic judgments and triage decisions for patients with acute congestive heart failure. Chest 2002; 121: 1610-7.
54. Opasich C, Tavazzi L. Riflessioni sul problema organizzativo dell'assistenza al paziente con scompenso cardiaco cronico. G Ital Cardiol 1998; 28: 913-9.
55. Storrow AB, Collins SP, Lyons MS, Wagoner LE, Gibler WB, Lindsell CJ. Emergency department observation of heart failure: preliminary analysis of safety and cost. Congest Heart Fail 2005; 11: 68-72.
56. Delgado DH, Rao V, Ross HJ, Verna S, Smedira NG. Mechanical circulatory assistance: state of art. Circulation 2002; 106: 2046-50.
57. Raval AN, Marchiori GE, Arnold JM. Improving the continuity of care following discharge of patients hospitalized with heart failure: is the discharge summary adequate? Can J Cardiol 2003; 19: 365-70.
58. Koelling TM, Johnson ML, Cody RJ, et al. Discharge education improves clinical outcomes in patients with chronic heart failure. Circulation 2005; 111: 179-85.
59. Coleman EA, Smith JD, Raha D, Min SJ. Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med 2005; 165: 1842-7.
60. Remes J, Miettinen H. Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315-21.
61. Fox KF, Cowie MR, Wood DA, Coats AJ, Poole-Wilson PA, Sutton GC. A rapid access heart failure clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community. Fur J Heart Fail 2000; 2: 423-9.
62. Fuat A, Hungin AP, Murphy JJ. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 2003; 326; 196-201.
63. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al, for the European Society of Cardiology. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2003; 24: 13-5.
64. Komajda M, Lapuerta P, Hermans N, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 2005; 26: 1653-9.
65. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004; 164: 1978-84.
66. Adlam D, Silcocks P, Sparrow N. Using BNP to develop a risk score for heart failure in primary care. Eur Heart J 2005; 26: 1086-93.
67. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997; 95: 2660-7.
68. Butler J, Khadim G, Paul KM, et al. Selection of patients for heart transplantation in the current era of heart failure therapy. J Am Coll Cardiol 2004; 43: 787-93.
69. Frigerio M, Gronda E, Mangiavacchi M, et al. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure. J Heart Lung Transplant 1997; 16: 160-8.
70. Cimato TR, Jessup M. Recipient selection in cardiac transplantation: contraindications and risk factors for mortality. J Heart Lung Transplant 2002; 21: 1161-73.
71. Costanzo MR, Augustine S, Bourge R, et al. Selection and treatment of candidates for heart transplantation. A statement for health profesionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology. Circulation 1995; 92: 3593-612.
72. Aaronson KD, Patel H, Pagani FD. Patient selection for left ventricular assist device therapy. Ann Thorac Surg 2003; 75 (Suppl 6): S29-S35.
73. Stevenson LW, Rose EA. Left ventricular assist device. Bridge to transplantation, recovery, and destination for whom? Circulation 2003; 108: 3059-63.
74. Deng MC, Young JB, Stevenson LW, et al, on behalf of the Board of Directors of the International Society of Heart and Lung Transplantation (ISHLT). Destination mechanical circulatory support: proposal for clinical standards. J Heart Lung Transplant 2003; 22: 365-9.
75. Aaronson KD, Eppinger M, Dyke DB, Wright S, Pagani FD. Left ventricular assist device therapy improves utilization of donor hearts. J Am Coll Cardiol 2002; 39: 1247-54.
76. Deng M, Loebe M, El-Banayosy A, et al. Mechanical circulatory support for advanced heart failure: effect of patient selection and outcome. Circulation 2001; 103: 231-7.
77. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med 1999; 159: 29-34.
78. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II, The aging heart in health: links to heart disease. Circulation 2003; 107: 346-54.
79. Rich MW, Kitzman DW. Heart failure in octogenarians: a fundamentally different disease. Am J Geriatr Cardiol 2000; 9: 97-104.
80. De Geest S, Steeman E, Leventhal ME, et al. Complexity in caring for an ageing heart failure population: concomitant chronic conditions and age related impairments. Eur J Cardiovasc Nurs 2004; 3: 263-70.
81. Lien CT, Gillespie ND, Struthers AD, McMurdo ME. Heart failure in frail elderly patients: diagnostic difficulties, comorbidities, polypharmacy and treatment dilemmas. Eur J Heart Fail 2002; 4: 91-8.
82. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59: 255-63.
83. Pulignano G, Del Sindaco D, Tavazzi L, et al, for the INCHF Investigators. Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J 2002; 143: 45-55.
84. De Geest S, Scheurweghs L, Reynders I, et al. Differences in psychosocial and behavioral profiles between heart failure patients admitted to cardiology and geriatric wards. Eur J Heart Fail 2003; 5: 557-67.
85. Rich MW. Office management of heart failure in the elderly. Am J Med 2005; 118: 342-8.
86. Stuck AE, Siu AL, Wieland GD, Adams J, Rubenstein LZ. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 1993; 342: 1032-6.
87. Del Sindaco D, Zuccalà G, Pulignano G, Cocchi A. La valutazione multidimensionale dell'anziano con scompenso cardiaco. Ital Heart J 2004; 5 (Suppl 10): 26S-36S.
88. Società Italiana di Gerontologia e Geriatria. Linee guida sulla valutazione multidimensionale nell'anziano fragile. http://www.sigg.it
89. Filippi A, Sessa E, Pecchioli S, Trifò G, Samani F, Mazzaglia G. Homecare for patients with heart failure in Italy. Ital Heart J 2005; 6: 573-7.
90. Ahmed A. American College of Cardiology/American Heart Association chronic heart failure evaluation and management guidelines: relevance to geriatric practice. J Am Geriatr Soc 2003; 51: 123-6.
91. Fonarow GC. Quality indicators for the management of heart failure in vulnerable elders. Ann Intern Med 2001; 135: 694-702.
92. Higashi T, Shekelle PG, Adams JL, et al. Quality of care is associated with survival in vulnerable older patients. Ann Intern Med 2005; 143: 274-81.
93. Goodlin SJ, Hauptman PJ, Arnold R, et al. Consensus statement: palliative and supportive care in advanced heart failure. J Card Fail 2004; 10: 200-9.
94. Rosenwax LK, McNamara B, Blackmore AM, Holman CD. Estimating the size of a potential palliative care population. Palliat Med 2005; 19: 556-62.
95. Opasich C, DeFeo S, Barbieri M, Majani G. Qualità dell'assistenza nello scompenso cardiaco terminale: una riflessione "multidisciplinare". Ital Heart J Suppl 2003; 4: 112-8.
96. Levenson JW, McCarthy EP, Lynn J, Davis RB, Phillips RS. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000; 48 (Suppl): S101-S109.
97. Coventry PA, Grande GE, Richards DA, Todd CJ. Prediction of appropriate timing of palliative care for older adults with non-malignant life-threatening disease: a systematic review. Age Ageing 2005; 34: 218-27.
98. Gibbs JSR, McCoy ASM, Gibbs LME, Rogers AE, Addington-Hall JM. Living with and dying from heart failure: the role of palliative care. Heart 2002; 88 (Suppl II): II36-II39.
99. Sommaruga M, Bettinardi O, Opasich C. La comunicazione tra medico e paziente con scompenso cardiaco cronico può aiutare ad ottenere gli obiettivi terapeutici. Come renderla efficace? Ital Heart J 2001; 2 (9 Suppl): 945-57.
100. Mac Mahon KM, Lip GY Psychological factors in heart failure: a review of the literature. Arch Intern Med 2002; 162: 509-16.
101. Task Force per le Attività di Psicologia in Cardiologia Riabilitativa. e Preventiva, Gruppo Italiano di Cardiologia Riabilitativa. e Preventiva. Linee guida per le attività di psicologia in cardiologia riabilitativa e preventiva. Monaldi Arch Chest Dis 2003; 60: 184-234.
102. Jowsey SG, Taylor ML, Schneekloth TD, Clark MM. Psychosocial challenges in transplantation. J Psychiatr Pract 2001; 7: 404-14.
103. Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J 2005; 149: 664-9.
104. Krumholz HM, Butler J, Miller J, et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 1998; 97: 958-64.